These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29542269)

  • 81. Development, implementation, and associated challenges of a new HDR brachytherapy program.
    Scanderbeg DJ; Yashar C; Ouhib Z; Jhingran A; Einck J
    Brachytherapy; 2020; 19(6):874-880. PubMed ID: 32950407
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Quality Control of Brachytherapy Equipment in Kazakhstan: Current Stage and Minimum Requirements.
    Tulegenova A; Datbayev K; Seitov O; Omirzak M; Guliyev N; Mussakhanov D
    Asian Pac J Cancer Prev; 2023 Sep; 24(9):3133-3138. PubMed ID: 37774065
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Medical Physics Practice Guideline (MPPG) 11.a: Plan and chart review in external beam radiotherapy and brachytherapy.
    Xia P; Sintay BJ; Colussi VC; Chuang C; Lo YC; Schofield D; Wells M; Zhou S
    J Appl Clin Med Phys; 2021 Sep; 22(9):4-19. PubMed ID: 34342124
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Electronic intracavitary brachytherapy quality management based on risk analysis: The report of AAPM TG 182.
    Thomadsen BR; Biggs PJ; Cardarelli GA; Chu JCH; Cormack RA; Feng W; Heaton HT; Hiatt JR; Law JN; Limmer JP; Ouhib Z; Pai S; Pillai S; Ringor MR; Rivard MJ; Waldron TJ; Caldwell BS; Holt RW; Pike TL; Safigholi H; Stacey C; Weigand F
    Med Phys; 2020 Apr; 47(4):e65-e91. PubMed ID: 31702063
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Risk and Quality in Brachytherapy From a Technical Perspective.
    Poder J; Rivard MJ; Howie A; Carlsson Tedgren Å; Haworth A
    Clin Oncol (R Coll Radiol); 2023 Aug; 35(8):541-547. PubMed ID: 36682968
    [TBL] [Abstract][Full Text] [Related]  

  • 86. How to use the Paris system in the year 2001?
    Hennequin C; Mazeron JJ; Chotin G
    Radiother Oncol; 2001 Jan; 58(1):5-6. PubMed ID: 11165674
    [No Abstract]   [Full Text] [Related]  

  • 87. [Intracoronary brachytherapy].
    Delannes M; Latorzeff I; Carrie C; Alibelli MJ; Bonnet J; Duthil P
    Cancer Radiother; 2002 Apr; 6(2):116-8. PubMed ID: 12035483
    [No Abstract]   [Full Text] [Related]  

  • 88. Patient Engagement: an Assessment of Canadian Radiotherapy Programs' Current Practices, Perceived Barriers, and Facilitators.
    Robin G; Brown E; Davis CA; Bird L; Wilson L; Halperin R; Brundage M; Croke J; Harper C; Giuliani M; ; Caissie A
    J Cancer Educ; 2022 Dec; 37(6):1834-1841. PubMed ID: 34518991
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Prostate cancer: impact of national guidelines on brachytherapy monotherapy.
    Johnson J; Roach M
    Nat Rev Urol; 2014 Apr; 11(4):195-6. PubMed ID: 24619374
    [No Abstract]   [Full Text] [Related]  

  • 90. [Quality assurance for high dose rate brachytherapy equipment - practice and agenda - ].
    Kawamura S
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2011; 67(8):945-52. PubMed ID: 21869548
    [No Abstract]   [Full Text] [Related]  

  • 91. An examination of the consistency and accuracy of computerized brachytherapy dose predictions.
    Tolbert DD; Reed SA
    Int J Radiat Oncol Biol Phys; 1981 May; 7(5):675-82. PubMed ID: 7275734
    [No Abstract]   [Full Text] [Related]  

  • 92. Examining the evidence in pursuit of the highest possible brachytherapy standards.
    Buyyounouski MK; Viswanathan AN; Prestidge BR;
    Brachytherapy; 2014; 13(1):15-6. PubMed ID: 24055009
    [No Abstract]   [Full Text] [Related]  

  • 93. [Handling manual for brachytherapy sources. IV. Manual of safety use in brachytherapy].
    Hayami A; Maruyama T
    Radioisotopes; 1987 Jun; 36(6):307-16. PubMed ID: 3671793
    [No Abstract]   [Full Text] [Related]  

  • 94. ABS brachytherapy consensus guidelines.
    Horwitz EM;
    Brachytherapy; 2012; 11(1):4-5. PubMed ID: 22265433
    [No Abstract]   [Full Text] [Related]  

  • 95. [Radioactive particles implantation treatment technology management specification interpretation and clinical application of quality control index].
    Hu XK; Zhang FJ
    Zhonghua Yi Xue Za Zhi; 2017 May; 97(19):1441-1443. PubMed ID: 28535633
    [No Abstract]   [Full Text] [Related]  

  • 96. ASTRO Editorial: The Multidisciplinary Management of Metastatic Disease of the Femur: Toward Optimizing Outcomes.
    Tseng YD; Salerno KE; Balboni TA;
    Pract Radiat Oncol; 2021; 11(2):89-91. PubMed ID: 33012697
    [No Abstract]   [Full Text] [Related]  

  • 97. Clinical practice guidelines: help or hindrance?
    Cockeram AW
    J Pediatr Gastroenterol Nutr; 1999 Apr; 28(4):362-3. PubMed ID: 10204497
    [No Abstract]   [Full Text] [Related]  

  • 98. COMP report: CPQR technical quality control guidelines for low-dose-rate permanent seed brachytherapy.
    Beaulieu L; Radford DA; Eduardo Villarreal-Barajas J
    J Appl Clin Med Phys; 2018 May; 19(3):13-18. PubMed ID: 29542269
    [TBL] [Abstract][Full Text] [Related]  

  • 99. COMP report: CPQR technical quality control guidelines for brachytherapy remote afterloaders.
    Frenière N
    J Appl Clin Med Phys; 2018 Mar; 19(2):39-43. PubMed ID: 29417727
    [TBL] [Abstract][Full Text] [Related]  

  • 100. COMP report: CPQR technical quality control guidelines for treatment planning systems.
    Villarreal-Barajas JE
    J Appl Clin Med Phys; 2018 Mar; 19(2):35-38. PubMed ID: 29377492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.